Single Chain Antibody definition

Single Chain Antibody means an Antibody having binding affinity for an Antigen whereby such Antibody comprises (i) a polypeptide segment having a light chain variable region, (ii) a polypeptide having a heavy chain variable region, and (iii) at least one peptide linker linking those polypeptides into a single chain polypeptide.
Single Chain Antibody or “SCA” means an Antibody comprising (a) a polypeptide segment having a light chain variable region, (b) a polypeptide segment having a heavy chain variable region, and (c) at least one peptide linker linking those polypeptides into a single chain polypeptide.
Single Chain Antibody means one single-chain antibody binding to a certain antigen and the cDNA which produces the SINGLE-CHAIN ANTIBODY as specified in Schedule I attached hereto and made a part hereof.

Examples of Single Chain Antibody in a sentence

  • Kranz, Efficient Tumor Cell Lysis Mediated by A Bispecific Single Chain Antibody Expressed in Escherichia Coli, J.

  • RPRP and Introgen will mutually agree upon a Product Plan and Budget for the Single Chain Antibody Products, as contemplated in Section 3.4 of the Agreement.

  • In addition, RPRP agrees to include in the reports provided to the Development Committee under Section 2.4.3 of the Agreement a summary of RPRP's activities with respect to the research and development of the Single Chain Antibody Products.

  • Localization of Isoketal Adducts In Vivo Using an Anti- Isoketal Single Chain Antibody.

  • Patil G, Strategies for Production of a Recombinant Single Chain Antibody Fragment in Escherichia coli, PhD thesis, 2009, Natural Science Faculty, University of Halle, Germany.

  • Daunert, "Fusion Proteins of a Single Chain Antibody and Photoproteins for Assay development in the Detection of Salmonella Antigen", 216th ACS National Meeting, March 21, 1999, Anaheim, CA.

  • Bejcek et al., Development and Characterization of Three Recombinant Single Chain Antibody Fragments (scFvs) Directed against the CD19 Antigen, 55 CANCER RES.

  • Health systems have three funda- mental goals: improving health, providing services responding to the populations needs and establishing systems of fair financing (WHO, 2000).

  • M., Cygler, M.: Structure of a Single -Chain Antibody Variable Domain (Fv) Fragment Complexed with a Carbohydrate Antigen at 1.7-A Resolution .

  • However, RPRP and Introgen acknowledge that much of the preliminary research and preclinical studies on the Collaboration Products that are Single Chain Antibody Products may be performed by RPRP in France.


More Definitions of Single Chain Antibody

Single Chain Antibody means a single chain polypeptide having a binding affinity for a cell surface antigen, and comprising: (a) a [***] having a [***], (b) a [***] having a [***], and (c) at least [***] the [***] and [***] into a single chain polypeptide. *** Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4), and 240.24b-2

Related to Single Chain Antibody

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compound means [***].

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Biosimilar means a biological product that is highly similar to a specific reference biological

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • ingredient means any substance, including a food additive used in the manufacture or preparation of food and present in the final product, possibly in a modified form;